Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Nature and Science of Sleep
|
April 29, 2025
Gait Characteristics and Neuroanatomical Alterations in Obstructive Sleep Apnea-Hypopnea Syndrome
Jialiu Jiang, Yuting Mo, Zulalai Abuduwaili, et al.
CNS Neuroscience & Therapeutics
|
July 13, 2024
Connectome gradient dysfunction contributes to white matter hyperintensity-related cognitive decline
Dan Yang, Yi Tan, ZhiXin Zhou, et al.
Brain Communications
|
March 30, 2026
Synergistic effects of cerebral small vessel disease burden and plasma phosphorylated tau 181 on white matter microstructure and cognition in a Chinese cohort
Jingxian Xu, Hao-Jie Chen, Yichen Wang, et al.
ACS Sensors
|
November 24, 2025
A Surface-Engineered Microfluidic Platform with Algorithmic Optimization for Plasma Biomarker Detection in Alzheimer's Disease
Yue Cheng, Limoran Tang, Yi Tan, et al.
NPJ Digital Medicine
|
July 15, 2025
Deep adaptive learning predicts and diagnoses CSVD-related cognitive decline using radiomics from T<sub>2</sub>-FLAIR: a multi-centre study
Lili Huang, Zhuoyuan Li, Xiaolei Zhu, et al.
Alzheimer'S Research & Therapy
|
April 30, 2026
Performance of plasma pTau217, pTau181 and their ratios to Aβ42 in detecting Aβ pathology using a China-developed direct chemiluminescence assay
Dan Yang, Zhihong Ke, Nihong Chen, et al.
Journal of Medicinal Chemistry
|
March 13, 2024
Rational Design of PARP1/c-Met Dual Inhibitors for Overcoming PARP1 Inhibitor Resistance Induced by c-Met Overexpression
Zeren Sun, Lanjie Li, Bingxin Zhai, et al.
Journal of Medicinal Chemistry
|
March 7, 2026
Correction to "Discovery of Hydroxamic Acid Ester Derivatives as Second-Generation PRMT5 Inhibitors for the Treatment of Triple Negative Breast Cancer"
Xingxing Cheng, Zheqi Hu, Huihuan Mao, et al.
Journal of Medicinal Chemistry
|
January 13, 2026
Discovery of Oxime Ether Derivatives as Second-Generation PRMT5 Inhibitors for the Treatment of Triple Negative Breast Cancer
Xingxing Cheng, Zheqi Hu, Huihuan Mao, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Nature and Science of Sleep
|
April 29, 2025
Gait Characteristics and Neuroanatomical Alterations in Obstructive Sleep Apnea-Hypopnea Syndrome
Jialiu Jiang, Yuting Mo, Zulalai Abuduwaili, et al.
CNS Neuroscience & Therapeutics
|
July 13, 2024
Connectome gradient dysfunction contributes to white matter hyperintensity-related cognitive decline
Dan Yang, Yi Tan, ZhiXin Zhou, et al.
Brain Communications
|
March 30, 2026
Synergistic effects of cerebral small vessel disease burden and plasma phosphorylated tau 181 on white matter microstructure and cognition in a Chinese cohort
Jingxian Xu, Hao-Jie Chen, Yichen Wang, et al.
ACS Sensors
|
November 24, 2025
A Surface-Engineered Microfluidic Platform with Algorithmic Optimization for Plasma Biomarker Detection in Alzheimer's Disease
Yue Cheng, Limoran Tang, Yi Tan, et al.
NPJ Digital Medicine
|
July 15, 2025
Deep adaptive learning predicts and diagnoses CSVD-related cognitive decline using radiomics from T<sub>2</sub>-FLAIR: a multi-centre study
Lili Huang, Zhuoyuan Li, Xiaolei Zhu, et al.
Alzheimer'S Research & Therapy
|
April 30, 2026
Performance of plasma pTau217, pTau181 and their ratios to Aβ42 in detecting Aβ pathology using a China-developed direct chemiluminescence assay
Dan Yang, Zhihong Ke, Nihong Chen, et al.
Journal of Medicinal Chemistry
|
March 13, 2024
Rational Design of PARP1/c-Met Dual Inhibitors for Overcoming PARP1 Inhibitor Resistance Induced by c-Met Overexpression
Zeren Sun, Lanjie Li, Bingxin Zhai, et al.
Journal of Medicinal Chemistry
|
March 7, 2026
Correction to "Discovery of Hydroxamic Acid Ester Derivatives as Second-Generation PRMT5 Inhibitors for the Treatment of Triple Negative Breast Cancer"
Xingxing Cheng, Zheqi Hu, Huihuan Mao, et al.
Journal of Medicinal Chemistry
|
January 13, 2026
Discovery of Oxime Ether Derivatives as Second-Generation PRMT5 Inhibitors for the Treatment of Triple Negative Breast Cancer
Xingxing Cheng, Zheqi Hu, Huihuan Mao, et al.
Page
of 4